Man Group’s Foghorn Therapeutics FHTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Hold
0
-$211K 2001
2023
Q1
Sell
-15,855
Closed -$101K 1768
2022
Q4
$101K Buy
+15,855
New +$101K ﹤0.01% 1900